Perioperative administration of nivolumab and chemotherapy is superior to chemotherapy alone in prolonging event-free survival (EFS) in adult patients with resectable stage II/IIIb disease. Non-small cell...
Jason Luke, M.D., Ph.D., associate professor of hematology/oncology and director of the Center for Cancer Immunotherapy at UPMC Hillman Cancer Center, unique from RELATIVITY-047 trial (NCT03470922)...
Recent Comments